What Causes Mood Swings: A Glossary of Triggers and Contributing Factors

Hormonal Fluctuations

Hormonal fluctuations refer to the natural rise and fall of chemical messengers such as estrogen, progesterone, testosterone, and thyroid hormones that regulate mood‑related brain circuits. When these levels shift rapidly, the brain’s emotional centers receive altered signals, producing sudden changes in affect.

Life‑stage transitions—puberty, the menstrual cycle, pregnancy, postpartum, and menopause—create predictable windows where hormone concentrations swing dramatically. Each phase carries a characteristic pattern; for example, the luteal phase of the menstrual cycle often brings a pre‑menstrual dip in serotonin that many people experience as irritability or sadness.

Thyroid disorders add another layer: hyperthyroidism can mimic anxiety, while hypothyroidism often looks like low‑grade depression. Because thyroid hormone influences metabolic rate in neurons, even modest deviations from the reference range may amplify mood variability. These shifts can also interact with sex hormones, compounding the emotional impact.

• Puberty onset
• Menstrual cycle phases (follicular, luteal)
• Pregnancy and postpartum
• Perimenopause and menopause
• Thyroid dysfunction (hyper‑ or hypothyroidism)

Neurotransmitter Imbalance

Neurotransmitter imbalance describes a state in which the brain’s chemical messengers—primarily serotonin, dopamine, norepinephrine, and gamma‑aminobutyric acid (GABA)—are present at levels that do not support stable affect regulation. Small deficits or excesses can tip the emotional set point toward rapid swings.

Genetic polymorphisms, chronic stress, and substance use (especially alcohol and stimulants) can alter synthesis, reuptake, or receptor sensitivity for these transmitters. The resulting dysregulation often appears as brief episodes of euphoria followed by sudden irritability or tearfulness. These patterns may repeat daily or cluster around specific triggers.

Because neurotransmitter systems interact, a primary deficit in serotonin can secondarily dampen dopamine signaling, compounding mood instability. Laboratory testing of cerebrospinal fluid is rarely done clinically; diagnosis relies on symptom patterns and response to targeted interventions. Clinicians often infer imbalance from the therapeutic effect of medications that modify these pathways.

• Serotonin
• Dopamine
• Norepinephrine
• GABA
• Glutamate

Sleep Disruption

Sleep disruption encompasses any pattern that reduces total sleep time, fragments sleep architecture, or misaligns the circadian rhythm with the external light‑dark cycle. The brain uses sleep to recalibrate emotional circuits; when this process is interrupted, affect regulation becomes fragile.

Common forms include chronic insomnia, shift‑work schedules, frequent night‑time awakenings, and untreated obstructive sleep apnea. Each reduces the proportion of slow‑wave and REM sleep, stages that are especially important for processing affective memories. The resulting sleep debt often manifests as heightened reactivity to minor stressors the following day.

Even a single night of truncated sleep can raise cortisol and lower prefrontal cortex activity, producing a measurable increase in negative affect the next morning. Consistent sleep hygiene—regular bedtime, dark environment, limited caffeine—helps stabilize this neuroendocrine feedback loop. Over weeks, this practice reduces the frequency and amplitude of mood swings.

• Insomnia (difficulty falling or staying asleep)
• Irregular shift schedules
• Frequent nocturnal awakenings
• Obstructive sleep apnea
• Delayed sleep phase syndrome

Nutritional Deficiencies

Nutritional deficiencies refer to insufficient intake or absorption of micronutrients that serve as cofactors for neurotransmitter synthesis and neuronal membrane integrity. When key vitamins, minerals, or fatty acids fall below functional thresholds, the brain’s capacity to maintain steady mood diminishes.

Vitamin D, B‑complex vitamins (especially B6, B9, B12), magnesium, zinc, and long‑chain omega‑3 fatty acids have the strongest evidence linking low status to affective lability. Deficiency may arise from restricted diets, malabsorption syndromes, or increased demand during growth and illness.

Correcting a shortfall typically involves dietary diversification—fatty fish, leafy greens, legumes, nuts, and fortified foods—plus targeted supplementation when laboratory values confirm a deficit. Repletion can take weeks to months before mood stability improves noticeably. Monitoring serum levels guides dosage and prevents excess.

• Vitamin D
• Vitamin B6, B9 (folate), B12
• Magnesium
• Zinc
• Omega‑3 fatty acids (EPA/DHA)

Psychosocial Stressors

Psychosocial stressors are external or interpersonal demands that exceed an individual’s perceived coping resources, activating the hypothalamic‑pituitary‑adrenal axis and altering limbic reactivity. The resulting surge in cortisol and inflammatory cytokines can produce rapid shifts between anxiety, irritability, and low mood.

Typical sources include high‑pressure work environments, relationship conflict, financial insecurity, caregiving burden, and exposure to traumatic events. The intensity and duration of each stressor, as well as the presence of supportive relationships, shape the magnitude of mood variability. Cumulative exposure often leads to a sensitized stress response, making even minor triggers feel overwhelming.

Cognitive appraisal—how a person interprets a situation—mediates the physiological impact. Maladaptive patterns such as catastrophizing or rumination amplify the emotional swing, whereas problem‑focused coping and mindfulness practices can dampen the cascade. Therapeutic interventions that restructure appraisal often reduce swing frequency within weeks.

• Workplace pressure and deadlines
• Relationship disputes or loss
• Financial strain or debt
• Caregiving responsibilities
• Past trauma or ongoing abuse

Medical Conditions and Medications

Medical conditions and medications can directly modulate mood circuitry or indirectly affect it through metabolic, hormonal, or inflammatory pathways. Recognizing these contributors is essential because they may require disease‑specific treatment rather than solely symptomatic management. A thorough clinical review often uncovers a reversible cause.

Endocrine disorders such as diabetes mellitus, Cushing’s syndrome, and Addison’s disease produce glucose or cortisol fluctuations that destabilize affect. Neurological conditions—multiple sclerosis, Parkinson’s disease, and traumatic brain injury—disrupt neural networks that regulate emotion. Both categories frequently coexist with psychiatric comorbidity, compounding swing severity.

Pharmacologic agents—including corticosteroids, beta‑blockers, certain antihypertensives, hormonal contraceptives, and opioid analgesics—list mood lability as a known adverse effect. Dose adjustments, timing changes, or alternative agents can often mitigate the problem without compromising the primary indication. Patients should discuss any new mood changes with the prescribing clinician promptly.

• Thyroid disease (hyper‑/hypothyroidism)
• Diabetes mellitus
• Cushing’s syndrome / Addison’s disease
• Neurological disorders (MS, Parkinson’s, TBI)
• Corticosteroids, beta‑blockers, hormonal contraceptives, opioids